<DOC>
	<DOCNO>NCT01819922</DOCNO>
	<brief_summary>This study design assess effect one single dose PF-05175157 metabolic cardiopulmonary parameter , treadmill exercise healthy volunteer .</brief_summary>
	<brief_title>Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject non child bearing potential , age 18 40 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 18 28 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Subjects maximum effort study ( peak RER &gt; 1.05 ) normal exercise capacity define peak VO2 ≥80 % ≤120 % predict evidence inducible ischemia significant arrhythmia time peak aerobic capacity test 3 ( ±1 ) day prior initiation study . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . History smoke past 5 year history evidence habitual use ( non smoke ) tobacco nicotinecontaining product within 3 month Screening positive cotinine test Screening Day 3 ( ±1 ) . Dry eye symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Cardiopulmonary exercise testing</keyword>
	<keyword>metabolic parameter</keyword>
	<keyword>Diabetes Mellitus Type 2</keyword>
</DOC>